Article Details
Retrieved on: 2021-05-07 06:11:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AstraZeneca PLC said Friday that the combination of its Imfinzi drug and tremelimumab with chemotherapy showed an overall survival benefit in its ...
Article found on: www.marketwatch.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here